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Background: The Center for Disease Control and Prevention recommends that high-risk groups, like sexually active
men who have sex with men (MSM), receive HIV testing and counseling at least annually. The objective of this
study was to investigate the relationship between voluntary repeat HIV testing and sexual risk behavior in MSM
receiving rapid serologic and nucleic acid amplification testing.
Methods: We performed a cohort study to analyze reported risk behavior among MSM receiving the “Early Test”, a
community-based, confidential acute and early HIV infection screening program in San Diego, California, between
April 2008 and July 2014. The study included 8,935 MSM receiving 17,333 “Early Tests”. A previously published risk
behavior score for HIV acquisition in MSM (i.e. Menza score) was chosen as an outcome to assess associations
between risk behaviors and number of repeated tests.
Results: At baseline, repeat-testers (n = 3,202) reported more male partners and more condomless receptive anal
intercourse (CRAI) when compared to single-testers (n = 5,405, all P <0.001). In 2,457 repeat testers there was a
strong association observed between repeated HIV tests obtained and increased risk behavior, with number of male
partners, CRAI with high risk persons, non-injection stimulant drug use, and sexually transmitted infections all increasing
between the first and last test. There was also a linear increase of risk (i.e. high Menza scores) with number of tests up
to the 17th test. In the multivariable mixed effects model, more HIV tests (OR = 1.18 for each doubling of the number
of tests, P <0.001) and younger age (OR = 0.95 per 5-year increase, P = 0.006) had significant associations with high
Menza scores.
Conclusions: This study found that the highest risk individuals for acquiring HIV (e.g. candidates for antiretroviral
pre-exposure prophylaxis) can be identified by their testing patterns. Future studies should delineate causation versus
association to improve prevention messages delivered to repeat testers during HIV testing and counseling sessions.
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ally active MSM, receive HIV testing and counseling at* Correspondence: mhoenigl@ucsd.edu; slittle@ucsd.edu
Original data of this manuscript have been presented in part at CROI 2015 in
Seattle, USA (Poster Control IDs 2086188 and 2082732).
1AntiViral Research Center, Division of Infectious Diseases, Department of
Medicine, University of California, San Diego, 200 West Arbor Drive #8208,
San Diego, CA 92103, USA
Full list of author information is available at the end of the article
© 2015 Hoenigl et al. Open Access This articl
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeleast annually [6]. To address this recommendation,
community-based, confidential HIV screening programs
that include screening for acute HIV (i.e. detect HIV
antigen in antibody negative persons), like the “Early
Test” in San Diego, California [7], have been imple-
mented in many US metropolitan areas. Higher rates of
repeat testing and counseling have been reported in
persons with more behavioral risks for HIV acquisition
[8–10], though most of these studies were conducted
either in resource limited settings or more than 10 years
ago (i.e. before the era of rapid HIV antibody or acute
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sessment of recent behavioral risks, pre-test counseling
(in some settings), and rapid provision of HIV test re-
sults. Detection of HIV infection is often associated with
at least transiently reduced risk behaviors and thus a
decreased risk of HIV transmission [14, 15]. When
test results are negative, however, the client could in-
terpret this as positive reinforcement that ongoing
risk behaviors are not sufficiently risky to result in
HIV infection [16]. In other words, reported risk be-
haviors without significant consequences may foster
greater risk in the future [17]. Thus, repeated nega-
tive HIV test results over time may provide an unin-
tentionally reassuring message that may ultimately
contribute to higher HIV-acquisition rates among re-
peat testers. In particular, acute infection screening
(i.e. nucleic acid amplification testing) provides HIV
status information related to very recent risk behav-
iors as well as greater certainty about a negative HIV
test result [18]. We investigated the relationship be-
tween voluntary repeat HIV testing and sexual risk
behavior in MSM receiving rapid serologic testing
and nucleic-acid testing (NAT).
Methods
In this retrospective analysis of a prospective cohort
study, we analyzed risk behavior reported for the previ-
ous 12 months in individuals who enrolled in the “Early
Test” HIV screening program between April 2008 and
July 2014. The “Early Test” [19] is a community-based,
voluntary, confidential acute and early HIV infection
(AEH) screening program that provides point of care
rapid HIV serologic testing followed by routine reflex to
individual donation HIV NAT (NAT results are provided
in a second visit or, if negative, also with automated
voice mail or online) in all antibody-negative persons
[7, 20, 21]. With the “Early Test” program approxi-
mately 4000 individuals per month are screened free
of charge at five regular plus additional mobile testing
sites (including sites targeting MSM at the Lesbian, Gay,
Bisexual, Transgender Center and the Gay Men’s Health
Clinic; the San Diego County Health Department; the
AntiViral Research Center (AVRC); substance abuse
treatment centers; and special community event venues)
in San Diego, United States. Similar to other settings in
the United States, MSM bear by far the greatest burden
of HIV infection in San Diego, as reflected in the “Early
Test”, where 72 % of tests overall, 85 % of repeat testing
encounters, and 88 % of HIV diagnoses are made to
MSM. Since the “Early Test” does not routinely keep
track of individuals who repeatedly test over time,
tests were considered linked to the same individual if
the birth date and soundex of last-name and first-
name matched.Pre-test counseling was provided at each Early Test
visit throughout the study period and utilized a client-
centered harm reduction model offering personalized
risk reduction options. Risk behavior was collected by
using a risk assessment form with 19 detailed survey
questions (focusing primarily on sexual risk behavior,
substance use, sexually transmitted infection (STI)
diagnoses – all reported for the prior 12 months – and
demographics). Survey questions were assessed and the
form filled out by the testing staff before each HIV test-
ing encounter, and data was later entered into the data
system (always in duplicate to minimize data entry
errors). After testing, clients were recommended to
come back 6 months later for the next testing encounter.
Males and female-to-male transsexual persons who re-
ported sexual contact with one or more male partners
during the previous 12 months were included in the
analysis. We excluded (1) those who were diagnosed
with HIV (irrespective of HIV stage) at the first test
since these participants did not have the opportunity to
become repeat testers, and (2) those with only one
“Early Test” who had repeat tests required as part of
their participation in another study (Fig. 1). AEH was
characterized using previously published criteria for
serologic and virologic test results [22]. We evaluated
the predictive potential (for AEH versus HIV negatives)
of a previously published risk behavior score for HIV ac-
quisition in MSM repeat testers [23] as an outcome
measure to assess changes in risk behavior. The shorter
version of this score (i.e. the Menza score), included four
variables: diagnosis or history of STI, use of metham-
phetamine or inhaled nitrites (i.e. poppers) in the prior
6 months, 10 or more male sex partners in the prior
year, and unprotected anal intercourse with someone
who is HIV positive in the prior year [23]. Two modi-
fications were necessary for our study: (1) diagnosis or
history of STI was modified to self-reported diagnosis
of STI within the last 12 months, and (2) time period
of methamphetamine or inhaled nitrite use was in-
creased to last 12 months (as we did not have data
available for last 6 months). Performance of the Menza
score in our cohort was evaluated using receiver oper-
ating characteristics (ROC) analysis and area under
the curve (AUC) value, including 95 % confidence
interval (CI) displayed.
Our main analyses focused on: (1) baseline risk behav-
ior in single- and repeat- testers, and (2) risk behavior
over time in repeat testers.
Baseline risk behavior in single and repeat testers
For the analysis of baseline risk behavior, we evaluated
the differences in risk behavior reported at the initial
HIV screening between single testers and repeat testers.
To evaluate the difference between single and repeat
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in the 12 months prior to testing using χ2 and Mann
Whitney U test. To identify baseline characteristics
that were associated with repeat testing, we used Cox
proportional-hazards regression, modeling the time
from initial test to (1) second test for repeat testers or
(2) end of follow-up period for single testers. Univariate
analyses were performed, and variables with P <0.20
were included in the multivariable model. Variables in
the final model were selected with a forward stepwise
procedure. Hazard ratios (HR) including 95 % CI were
displayed.
Risk behavior at first and last test in repeat testers
For the comparison of risk behavior reported at the first
and last test in repeat testers, those with incomplete
basic risk data at their first or last test (i.e. number of
male partners, STI and drug use), and those who had
their first and last test less than 180 days apart were
additionally excluded (as analysis focused on risk behav-
ior reported for the prior 12 months, Fig. 1). Analyses of
changes in risk behaviors between the first and the mostrecent “Early Test” used the McNemar test and Wil-
coxon signed rank test.
Risk behavior and number of tests in repeat testers
Further, individuals with repeat “Early Test” visits who
received additional protocol-driven interval tests as part
of co-enrollment in another study (n = 44) were ex-
cluded from the analyses to evaluate risk behavior over
time in repeat testers (Fig. 1). Analyses of changes in risk
behaviors between the first and the most recent “Early
Test” was performed separately for those with 2 to 3, 4
to 5, and 6 or more tests as described above.
Risk behavior at each Early Test visit was further char-
acterized with the previously published Menza score
[23]. Since scores clustered around awarded points based
on four specific risk behaviors (i.e. weighted scores for
risk behavior vary between 1 and 11), and therefore did
not follow a discrete-count distribution, we dichoto-
mized scores based on the median: high risk (above the
mean of individuals’ median scores) or low risk (below
the mean). At each time point, the cumulative number
of HIV tests was used as the primary predictor and the
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trolling for follow-up time and age. Percentage of high
(i.e. above the mean) HIV behavioral risk scores by num-
ber of HIV tests was calculated for repeat testers using
local regression (Loess), a smoothing technique that al-
lows one to see a pattern without assuming a particular
distribution. Visual and Loess fitting suggested that thereTable 1 Comparison demographics and risk behavior at baseline. Re
period versus those with repeated HIV tests (those with two or mor




Number of male partners (median, IQR) 5 (3–10)
10 or more male partners 1624/5397 (30.1 %)
Intercourse with females also 594/5389 (11.0 %)
CIAI with male 3188/5347 (59.6 %)
CRAI 2611/5343 (48.9 %)
CRAI and 5 or more male partners 1544/5342 (28.9 %)
CRAI and 10 or more male partners 892/5342 (16.7 %)
CRAI with HIV positive 214/5097 (4.2 %)
CRAI with PWID 56/5281 (1.1 %)
CRAI with sex worker 21/5147 (0.4 %)
Worked as sex worker 84/3799 (2.2 %)
Syphilis c 101 (1.9 %)
Gonorrhea c 274 (5.1 %)
Chlamydia c 214 (4.0 %)
Any STI c 596 (11.0 %)
Methamphetamine, not injected 363 (6.7 %)
Non-injection stimulant drug use
(i.e. methamphetamine, cocaine, poppers,
GHB, ketamine, XTC)
1316 (24.4 %)
IDU 77 (1.4 %)
IDU with shared needles 35/5378 (0.7 %)
Demographic data
Age (years; median, IQR) 33 (26–43)
Male 5402 (100 %)
Hispanic origin 1434/5249 (27.3 %)
Race –
Caucasian 3513/5066 (69.3 %)
African-American 317/5066 (6.3 %)
Asian 398/5066 (7.9 %)
Pacific Islander 142/5066 (2.8 %)
Native American 37/5066 (0.7 %)
Other 659/5066 (13.0 %)
CIAI, Condomless insertive anal intercourse; CRAI, Condomless receptive anal interc
range; MSM, Men who have sex with men; n.s., Not significant; PWID, Person who in
a Data available from all individuals if denominator not depicted
b Calculated using χ2 or Mann–Whitney U-test
c All self-reported diagnosis within the last 12 monthswas a linear relationship between the number of HIV
tests and the risk-behavior score up to approximately
the 17th test. As subsequent tests (from 18th test on-
ward) did not correspond to the same increase in higher
scores, numbers of tests were log-transformed to achieve
a linear relationship between number of tests and the
logit of high-risk scores.ported by individuals with a single HIV test during the study
e tests, and the subpopulation with five or more tests)
Repeat testers
(2 or more tests) a
P value b Repeat tester
(5 or more tests) a
P value b
3202 814
6 (3–12) <0.001 6 (4–14) <0.001
1120/3197 (35.0 %) <0.001 319 (39.2 %) <0.001
277/3192 (8.7 %) <0.001 64/813 (7.9 %) 0.007
1974/3170 (62.3 %) 0.016 491/804 (61.1 %) n.s.
1664/3167 (52.5 %) 0.001 434/802 (54.1 %) 0.003
1102/3165 (34.8 %) <0.001 306/802 (38.2 %) <0.001
632/3165 (20.0 %) <0.001 181/802 (22.6 %) <0.001
121/2947 (4.1 %) n.s. 19/725 (2.6 %) 0.043
29/3129 (0.9 %) n.s. 4/790 (0.5 %) n.s.
9/3052 (0.3 %) n.s. 1/764 (0.1 %) n.s.
45/2004 (2.3 %) n.s. 8/424 (1.9 %) n.s.
59 (1.8 %) n.s. 23 (2.8 %) n.s.
193 (6.0 %) n.s. 47 (5.8 %) n.s.
129 (4.0 %) n.s. 48 (5.9 %) 0.01
402 (12.6 %) 0.033 126 (15.5 %) <0.001
189 (5.9 %) n.s. 44 (5.4 %) n.s.
765 (23.9 %) n.s. 176 (21.6 %) n.s.
37 (1.2 %) n.s. 5 (0.6 %) n.s.
7/3180 (0.2 %) 0.006 0 0.021
32 (26–42) 0.011 32 (26–41) n.s.
3202 (100 %) n.s. 814 (100 %)
850/3105 (27.4 %) n.s. 203/785 (25.9 %) n.s.
– <0.001 – <0.001
2112/3021 (69.9 %) n.s. 547/783 (69.9 %) n.s.
143/3021 (4.7 %) 0.005 39/783 (5.0 %) n.s.
195/3021 (6.5 %) 0.022 52/783 (6.6 %) n.s.
53/3021 (1.8 %) 0.004 11/783 (1.4 %) 0.030
15/3021 (0.5 %) n.s. 1/783 (0.1 %) n.s.
503/3021 (16.7 %) <0.001 133/783 (17.0 %) 0.002
ourse; GHB, Gamma hydroxybutyrate; IDU, Injection drug use; IQR, Inter-quartile
jects drugs; STI, Sexually transmitted infection; XTC, Ecstasy
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gression models were performed for number of tests,
time since first HIV test and age, and odds ratios (OR)
including 95 % CI were displayed. In addition, associa-
tions between the number of tests (log2) and individual
known risk behaviors for HIV that were not included in
the Menza score were assessed by univariable mixed-
effects logistic regression models.
For statistical analysis SPSS 21 (SPSS Inc., Chicago, IL,
USA) and SAS 9.4 (SAS Institute, Cary, NC) were used.
The UCSD Human Research Protections Program ap-
proved the study protocol, consent, and all study related
procedures. All study participants provided voluntary,
written informed consent before any study procedures
were undertaken.
Results
A large population (n = 14,612 unique clients) under-
went HIV screening using the “Early Test” between April
2008 and July 2014, including 8,935 (61 %) unique
MSM (with 17,333 voluntary HIV tests). Notably, 10 %
(n = 892) of MSM participants reported sex with
women in the past year. Overall, 419 of 8,935 MSM
(4.69 %) were newly diagnosed with HIV infection, 219
(2.45 %) with chronic HIV infection, and 200 (2.24 %)
with AEH (125/200 (63 %) at their first “Early Test”,
75/200 (37 %) at a repeated visit). Incidence rate among
MSM repeat testers was 1.783 per 100 person years.
The Menza score [23] for HIV infection among MSM
was significantly higher in those with AEH than inTable 2 Risk behavior at the first and last test in 2,501 individuals un
Risk factor/risk behavior (within 12 months prior to test) First test
Individuals
reporting risk
10 or more male partners 871/2501
CRAI 1308/2474
CRAI and 5 or more male partners 859/2483
CRAI and 10 or more male partners 488/2483
CRAI with HIV positive male 76/2288
CRAI with sex worker 7/2436
CRAI with PWID 14/2437
Gonorrhea b 141/2501
Syphilis b 50/2501
Any STI b 317/2501
IDU with shared needles 9/2495
IDU 26/2501
Non-injection stimulant drug use (i.e. methamphetamine,
cocaine, poppers, GHB, ketamine, XTC)
562/2501
CRAI, Condomless receptive anal intercourse; GHB, Gamma hydroxybutyrate; IQR, In
who injects drugs; STI, Sexually transmitted infection; XTC, Ecstasy
a Median time between first and last test 714 days (IQR, 396–1191); individuals with
b All self-reported diagnosis within the last 12 monthsthose without HIV (median 3 points, interquartile range
(IQR) 0–11 versus median 0 point, IQR 0–4, P <0.001) and
displayed a moderate AUC value of 0.636 (95 % CI, 0.594–
0.677) for prediction of AEH.
Baseline risk behavior in single and repeat testers
A comparison of baseline risk behaviors in the 12
months prior to testing and demographics between
single and repeat testers is shown in Table 1. A total of
5,402 (63 %) single and 3,202 (37 %) repeat testers
(Fig. 1) were included in the analysis. Repeat testers had
up to 30 HIV tests during a mean period of follow-up of
104 weeks (standard deviation 84 weeks). Approximately
50 % of repeat testers had 2 or 3 tests and another 25 %
(n = 814) had 5 or more tests. At baseline, repeat testers
reported significantly more male partners and more con-
domless receptive anal intercourse (CRAI), and fewer
reported sexual contacts with females when compared
to single testers (all P <0.001).
In the multivariable analysis, CRAI (HR, 1.089; 95 % CI,
1.01–1.173; P = 0.026), 10 or more male partners (HR,
1.189; 95 % CI, 1.1–1.285; P <0.001), and not having sexual
contact with females also (HR, 0.824; 95 % CI, 0.725–
0.936; P = 0.003) were associated with repeat testing (also
included in the model: injection drug use, CRAI with a
HIV positive male, and STI).
Risk behavior at first and last test in repeat testers
Risk behaviors reported at the first and last test are sum-




Percentage P value using
McNemar test
34.83 % 970/2501 38.78 % <0.001
52.87 % 1323/2490 53.13 % n.s.
34.60 % 915/2495 36.67 % 0.028
19.65 % 580/2495 23.25 % <0.001
3.32 % 161/2422 6.65 % <0.001
0.29 % 12/2467 0.49 % n.s.
0.57 % 40/2464 1.62 % 0.002
5.64 % 189/2501 7.56 % 0.004
2.00 % 47/2501 1.88 % n.s.
12.67 % 348/2501 13.91 % n.s.
0.36 % 19/2501 0.76 % n.s.
1.04 % 28/2501 1.12 % ns
22.47 % 759/2501 30.35 % <0.001
terquartile range; IDU, Injection drug use; n.s., Not significant; PWID, Person
<180 days between tests were excluded
Table 3 Risk behavior reported at the first and last test in individuals undergoing repeat HIV testing: individuals with <180 days between tests were excluded
2–3 HIV tests (n = 1384; 47 HIV+) median time
first/last test 503 days (IQR, 317–845 days)
4–5 HIV tests (n = 565; 22 HIV+) median time
first/last test 844 days (IQR, 567–1229 days)
6 or more tests (n = 508; 18 HIV+) median time
first/last test 1333 days (IQR, 920–1705 days)
Risk factor/risk behavior
(within 12 months prior to test)
Prevalence of AEH
per individuals that
reported the risk a

















































































































































































































AEH, Acute and early HIV infection; CRAI, Condomless receptive anal intercourse; IQR, Interquartile range; IDU, Injection drug use; n.s., Not significant; PWID, Person who injects drugs; STI, Sexually transmitted infection;
a Among whole MSM study population after exclusion of those with newly diagnosed chronic HIV infection
b Calculated using McNemara test; P value displayed when below 0.1
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(median time between first and last test 714 days, IQR,
396–1191). Demographic characteristics of the evaluable
2,501 repeat testers reflected those observed for repeat
testers in Table 1. Using Wilcoxon’s signed rank sum
test, repeat testers reported significantly more male part-
ners (P = 0.001) and fewer female partners (P <0.001) at
the last test when compared to the first. Further, the
proportions of individuals reporting 10 or more male
partners alone or in combination with CRAI, CRAI with
an HIV-positive male, CRAI with a person who injects
drugs (PWID), gonorrhea, and non-injection stimulant
drug use (i.e. methamphetamine, cocaine, poppers,
gamma hydroxybutyrate, ketamine, ecstasy) were signifi-
cantly higher at the last test when compared to the first
(Table 2).
Risk behavior and number of tests in repeat testers
We also investigated risk increase between first and last
test by number of tests by dividing the study cohort in
three groups: those with 2 to 3 HIV tests (n = 1,384),
those with 4 to 5 tests (n = 565), and those with 6 or
more tests (n = 508). There was a positive association
between number of tests and CRAI with an HIV-
positive male, CRAI with a PWID, and non-injection
stimulant drug use (Table 3).
To investigate if there was an independent correlation
between number of tests over time and change in riskFig. 2 Percentage of high (i.e. ≥5 Menza-score points) HIV behavioral risk s
The bubble size reflects the denominator used to calculate the percentage
linear relationship between the y-axis (high risk score) and the x-axis (numb
that allows one to see a pattern without assuming a particular distributionbehavior, we performed analyses using the Menza score
at every single test as the outcome [23]. All tests with
complete data on the variables of the Menza score
(10,114 “Early tests” in 2,457 repeat testers) were in-
cluded. In these 2,457 repeat testers, there was a signifi-
cant increase of the score between baseline (median, 0;
IQR, 0–3) and final test (median, 3; IQR, 0–5; P <0.001).
The relationship between the number of tests and the
logit of high scores (i.e. ≥5; at 28 % of visits subjects re-
ported scores above this cutoff ) demonstrates that there
was a linear increase of the risk score with log number
of tests up to the 17th test (Fig. 2). Univariable mixed-
effects logistic regression models (Table 4) showed that
more HIV tests (OR = 1.16 for each doubling of the
number of tests, P <0.001), longer time since first HIV
test (OR = 1.08 per year, P <0.001), and younger age
(OR = 0.96 per 5 year increase of age, P = 0.048) were
all individually associated with high risk scores (i.e. ≥5).
In the multivariable mixed effects model, number of
tests (OR = 1.18 for each log2 of the number of
tests, P <0.001) and age (OR = 0.95 per 5-year in-
crease, P = 0.006) had significant associations with
high risk (i.e. ≥5 points), while time was no longer
significant (time and number of tests were highly
correlated (r = 0.67)).
A significant association between the number of tests
and high risk behavior was demonstrated also for risk
behaviors not included in the Menza score, i.e. thecores as modified from [23], by number of HIV tests in repeat testers.
of high scores. Linear Reg stands for linear regression, assuming a
er of tests). Loess stands for local regression, a smoothing technique
Table 4 Mixed effects model on factors associated with high-risk behavior: (i.e. ≥5 Menza-score points)
Variables included in the mixed effects model Univariable Multivariable
N Number of visits OR (95 % CI) P value OR (95 % CI) P value
Number of HIV tests (log2) 2457 10,114 1.16 (1.10–1.23) <0.0001 1.18 (1.11–1.24) <0.0001
Years since first test 2457 10,114 1.08 (1.04–1.13) <0.0001 – n.s.
Age (5-year increase) 2457 10,114 0.96 (0.93–1.00) 0.0479 0.95 (0.92–0.99) 0.0058
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CRAI with a PWID, and non-injection stimulant drug
use (Table 5).
Discussion
This is the largest modern study investigating the rela-
tionship between HIV risk behavior and HIV testing
among MSM in the United States. Analysis of risk be-
havior in subjects participating in an AEH screening
program (“Early Test”) over the past 6 years identified
two major findings. First, MSM who screened repeatedly
for HIV reported higher sexual risk behavior at baseline
than MSM who only screened once. Second, repeat HIV
testing was associated with an increase of risk behavior.
This is the first study to compare baseline risk behav-
ior in single versus repeat testers in an era where sero-
logic test results are available immediately and AEH can
be diagnosed by NAT screening. Prior to the era of NAT
screening, a handful of studies evaluated risk behaviors
in repeat and single testers. In a study by Fernyak [8],
the most frequent testers from 1995 to 1997 were those
who practiced the highest risk behaviors, and demon-
strated the highest incidence of HIV. In another study
by MacKellar [24], repeat testers from 1994 to 1998 were
more likely to report recent sexual risk behavior and
acquire HIV when compared to first-time testers. We
found that MSM in San Diego who repeatedly screened
for HIV with combined serologic and NAT, practice
higher sexual risk behavior at baseline than singleTable 5 Associations of number of HIV tests with other risk factors:




CRAI and 10 or more male partners 2457
CRAI with PWID 2455
CRAI with sex worker 2456
Non-injection stimulant drug use (i.e. methamphetamine, cocaine,
poppers, GHB, ketamine, XTC)
2457
IDU 2457
IDU with Shared needles 2455
CRAI, Condomless receptive anal intercourse; GHB, Gamma hydroxybutyrate; IDU, In
drugs; XTC, Ecstasytesters, but there were no differences identified between
these groups for most recreational drugs or recent STI.
This represents the biggest study to date analyzing the
associations between repeat testing and risk behavior in
repeat testers. In 2007, repeat testers accounted for more
than 80 % of HIV tests performed annually in the United
States [1], and when analyzing our program since 2008,
repeat tests accounted for 48 % (8,396/17,333) of volun-
tary HIV tests among MSM. Our main finding was that
repeat acute infection screening (i.e. rapid serologic test-
ing plus NAT) was independently associated with an
increase of risk behaviors between the baseline and the
last test. Rates of 10 or more male partners, CRAI with
an HIV-positive partner, CRAI with a PWID, non-
injection stimulant drug use, and self-reported STIs all
increased in line with testing frequency.
To assess change in risk over time we selected a previ-
ously validated score for prediction of HIV acquisition
among MSM repeat testers as the outcome [23]. When
evaluating that Menza risk behavior score at every single
“Early test” visit, there was an increase of the proportion
of individuals with high scores (i.e. ≥5 points) and the
number of tests observed. In the study by Menza, this 5-
point cut-off was associated with a cumulative 1-year
HIV seroconversion incidence of 3.6 % (derivation co-
hort) and 4.4 % (validation cohort) [23]. This increase of
risk behavior witnessed in our study is unlikely to simply
reflect the nation-wide increases in risk behaviors in





OR for risk factor per log2 increase of number of tests
OR (95 % CI) P value
10,185 0.99 (0.94–1.04) n.s.
10,223 1.11 (1.05–1.18) <0.001
10,098 1.35 (1.12–1.64) 0.002
10,093 1.20 (0.88–1.64) n.s.
10,251 1.37 (1.30–1.45) <0.001
10,251 0.91 (0.74–1.13) n.s.
10,209 0.95 (0.60–1.50) n.s.
jection drug use; n.s., Not significant; OR, Odds ratio; PWID, Person who injects
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ent predictor of increased risk-behavior in the mixed ef-
fects model. This finding may support a hypothesis that
provision of negative AEH screening results, which pro-
vide HIV status information related to very recent risk
behaviors, is independently associated with an increase
of risk behaviors between the baseline and the last test.
In other words, when a high-risk individual receives a
negative HIV result, they may rationalize prior risk be-
havior as relatively safe, potentially justifying an escal-
ation in subsequent risk [25]. However, although we
describe a strong relationship between testing and risk
behavior, we are not able to conclude causality, and also
the opposite may be true (i.e. clients increased risk be-
havior is the cause and not the result of repeat testing).
Nevertheless, our study provides provocative data that
warrants further testing of causation in future studies.
Our study has several additional limitations including
its single-center and retrospective design. Further,
though pre-test counseling offering personalized risk re-
duction options was provided at every single “Early
Test”, it is likely that the intensity of the counseling may
have been reduced at some of the repeated visits. We
hypothesized that the frequency of repeat testing is asso-
ciated with increased risk behavior, but we cannot rule
out that repeated tests are not a cause but just a result
of increased risk behavior (i.e. our cohort increased
their HIV testing as a response to their increased risk
behavior). Additionally, testing in primary care settings
and even home testing has become more normative
during the study period and individuals may have
tested outside the “Early Test” or associated studies,
which may have led to an underestimation of the pro-
portion of repeat testers. Further, some slight modifi-
cations of the previously validated Menza risk score
were necessary to fit our available data and analyses.
Finally, we cannot completely rule out that subjects
reported risk behaviors more honestly with time and
repeat testing.
Conclusions
In conclusion, this study demonstrates that the highest
risk individuals for acquiring HIV (e.g. candidates for
antiretroviral pre-exposure prophylaxis, referral for add-
itional behavioral counseling, STI screening) that are
usually identified by risk scores [26], may also be identi-
fied by their testing patterns. Strikingly, we found that
repeat HIV testing itself might be associated with an in-
crease in risk behavior. Although we were not able to
conclude causality, this finding may support a hypothesis
that rapid or immediate feedback of negative test results
may reinforce high-risk behavior. To compensate for this
reinforcement, intensified pre-test counseling among re-
peat testers may be necessary, particularly if increasingrisk behavior is documented [27]. This might be true es-
pecially in the setting of acute infection screening, which
provides HIV status information related to very recent
risk behaviors. Future studies that assess different inten-
sities and/or types of pre-test counseling (e.g. controlled
trial randomizing intervention in high-risk repeat testers
to reduce risk-taking behaviors) are needed to assess
causality. Such information will be crucial to better
understand the dynamics of risk-taking behavior and
frame HIV test counseling messages. If true, then new
prevention efforts should be developed and evaluated for
MSM who repeatedly screen for HIV.
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